207 related articles for article (PubMed ID: 21247671)
1. Pentoxifylline and tocopherol in the management of patients with osteoradionecrosis, the Portsmouth experience.
McLeod NM; Pratt CA; Mellor TK; Brennan PA
Br J Oral Maxillofac Surg; 2012 Jan; 50(1):41-4. PubMed ID: 21247671
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of pentoxifylline/tocopherol combination in the treatment of osteoradionecrosis.
Hayashi M; Pellecer M; Chung E; Sung E
Spec Care Dentist; 2015; 35(6):268-71. PubMed ID: 26084886
[TBL] [Abstract][Full Text] [Related]
3. Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment.
Lyons A; Ghazali N
Br J Oral Maxillofac Surg; 2008 Dec; 46(8):653-60. PubMed ID: 18562055
[TBL] [Abstract][Full Text] [Related]
4. Management of osteoradionecrosis of the jaws with pentoxifylline-tocopherol: a systematic review of the literature and meta-analysis.
Kolokythas A; Rasmussen JT; Reardon J; Feng C
Int J Oral Maxillofac Surg; 2019 Feb; 48(2):173-180. PubMed ID: 30205911
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic modalities in the treatment of osteoradionecrosis of the jaw.
McCaul JA
Oral Maxillofac Surg Clin North Am; 2014 May; 26(2):247-52. PubMed ID: 24794269
[TBL] [Abstract][Full Text] [Related]
6. Resolution of pain and complete healing of mandibular osteoradionecrosis using pentoxifylline and tocopherol: a case report.
Kahenasa N; Sung EC; Nabili V; Kelly J; Garrett N; Nishimura I
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Apr; 113(4):e18-23. PubMed ID: 22668439
[TBL] [Abstract][Full Text] [Related]
7. Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis.
Hille A; Christiansen H; Pradier O; Hermann RM; Siekmeyer B; Weiss E; Hilgers R; Hess CF; Schmidberger H
Strahlenther Onkol; 2005 Sep; 181(9):606-14. PubMed ID: 16170489
[TBL] [Abstract][Full Text] [Related]
8. Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial.
Delanian S; Chatel C; Porcher R; Depondt J; Lefaix JL
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):832-9. PubMed ID: 20638190
[TBL] [Abstract][Full Text] [Related]
9. Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial.
Delanian S; Depondt J; Lefaix JL
Head Neck; 2005 Feb; 27(2):114-23. PubMed ID: 15641107
[TBL] [Abstract][Full Text] [Related]
10. Osteoradionecrosis: a review of pathophysiology, prevention and pharmacologic management using pentoxifylline, α-tocopherol, and clodronate.
Rivero JA; Shamji O; Kolokythas A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Nov; 124(5):464-471. PubMed ID: 29103566
[TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline, tocopherol, and sequestrectomy are effective for the management of advanced osteoradionecrosis of the jaws-a case series.
Dos Anjos RS; de Pádua Walfrido GN; de Hollanda Valente RO; Gueiros LA; Carvalho AAT; Patel P; Porter S; Leão JC; Silva IHM
Support Care Cancer; 2021 Jun; 29(6):3311-3317. PubMed ID: 33106977
[TBL] [Abstract][Full Text] [Related]
12. Complete healing of severe osteoradionecrosis with treatment combining pentoxifylline, tocopherol and clodronate.
Delanian S; Lefaix JL
Br J Radiol; 2002 May; 75(893):467-9. PubMed ID: 12036843
[TBL] [Abstract][Full Text] [Related]
13. Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series.
Epstein MS; Wicknick FW; Epstein JB; Berenson JR; Gorsky M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Nov; 110(5):593-6. PubMed ID: 20955948
[TBL] [Abstract][Full Text] [Related]
14. Changing trends and the role of medical management on the outcome of patients treated for osteoradionecrosis of the mandible: experience from a regional head and neck unit.
D'Souza J; Lowe D; Rogers SN
Br J Oral Maxillofac Surg; 2014 Apr; 52(4):356-62. PubMed ID: 24480621
[TBL] [Abstract][Full Text] [Related]
15. Effects of pentoxifylline and tocopherol on a rat-irradiated jaw model using micro-CT cortical bone analysis.
Nguyen TTH; Eo MY; Seo MH; Myoung H; Kim SM; Lee JH
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3443-3452. PubMed ID: 31414224
[TBL] [Abstract][Full Text] [Related]
16. Pentoxifylline - a review of its use in osteoradionecrosis.
Lyons AJ; Brennan PA
Br J Oral Maxillofac Surg; 2017 Apr; 55(3):230-234. PubMed ID: 28034471
[TBL] [Abstract][Full Text] [Related]
17. Use of pentoxifylline and tocopherol in the management of osteoradionecrosis.
Patel V; Gadiwalla Y; Sassoon I; Sproat C; Kwok J; McGurk M
Br J Oral Maxillofac Surg; 2016 Apr; 54(3):342-5. PubMed ID: 26794083
[TBL] [Abstract][Full Text] [Related]
18. The management of osteoradionecrosis of the jaws--a review.
Rice N; Polyzois I; Ekanayake K; Omer O; Stassen LF
Surgeon; 2015 Apr; 13(2):101-9. PubMed ID: 25084627
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic use of pentoxifylline and tocopherol in patients who require dental extractions after radiotherapy for cancer of the head and neck.
Patel V; Gadiwalla Y; Sassoon I; Sproat C; Kwok J; McGurk M
Br J Oral Maxillofac Surg; 2016 Jun; 54(5):547-50. PubMed ID: 26975577
[TBL] [Abstract][Full Text] [Related]
20. Pentoxifylline-tocopherol-clodronate combination: A novel treatment for osteoradionecrosis of the temporal bone.
Glicksman JT; Khalili S; Fung K; Parnes LS; Agrawal SK
Head Neck; 2015 Dec; 37(12):E191-3. PubMed ID: 25821165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
